Vanguard Group »

Zentalis Pharmaceuticals shares owned by Vanguard Group

Quarter-by-quarter ownership of Zentalis Pharmaceuticals (ZNTL) shares owned by Vanguard Group from 13F filings

Historical chart of Vanguard Group investment in Zentalis Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Zentalis Pharmaceuticals held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Zentalis Pharmaceuticals by Vanguard Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $81M 5.4M 15.15
2023-09-30 $105M 5.2M 20.06
2023-06-30 $139M 4.9M 28.21
2023-03-31 $73M 4.2M 17.20
2022-12-31 $84M 4.2M 20.14
2022-06-30 $126M 4.5M 28.10
2022-03-31 $150M 3.2M 46.14
2021-09-30 $209M 3.1M 66.64
2021-06-30 $151M 2.8M 53.20
2021-03-31 $105M 2.4M 43.39
2020-12-31 $122M 2.3M 51.93
2020-09-30 $37M 1.1M 32.69
2020-06-30 $40M 827k 48.04